Last update 05 Dec 2024

HSK-42360

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HSK42360
Target
BRAF
Mechanism
BRAF inhibitors(Serine/threonine-protein kinase B-raf inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
BRAF mutation Solid TumorsLocally Advanced Malignant Solid NeoplasmBRAF V600 mutation-positive Neoplasms
Inactive Indication-
Originator Organization
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.
Active Organization
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.Tibet Haisco Pharmaceutical Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with HSK-42360
NCT06536400 / RecruitingPhase 1
A Phase I, Open-label, Dose-escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of HSK42360 in Patients With BRAF V600 Mutation Locally Advanced or Metastatic Solid Tumors
CTR20242136 / RecruitingPhase 1
评价HSK42360片在BRAF V600突变的晚期实体瘤患者中的安全性、耐受性以及药代/药效动力学的I期临床研究
[Translation] A phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics/pharmacodynamics of HSK42360 tablets in patients with advanced solid tumors with BRAF V600 mutations
100 Clinical Results associated with HSK-42360
Login to view more data
100 Translational Medicine associated with HSK-42360
Login to view more data
100 Patents (Medical) associated with HSK-42360
Login to view more data
100 Deals associated with HSK-42360
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
BRAF mutation Solid TumorsPhase 1
CN
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.
25 Jun 2024
Locally Advanced Malignant Solid NeoplasmPhase 1
CN
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.
25 Jun 2024
BRAF V600 mutation-positive NeoplasmsPhase 1
CN
Tibet Haisco Pharmaceutical Co. Ltd.
21 Jun 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free